Efficacy and safety of baricitinib in rheumatoid arthritis patients with moderate renal impairment: a multicenter propensity score matching study

Abstract Background This study aimed to compare the efficacy and safety of baricitinib in patients with rheumatoid arthritis (RA) receiving different doses based on renal function. Methods We conducted a retrospective study within the JAK Study Group, involving 23 facilities in Fukuoka Prefecture, e...

Descripció completa

Dades bibliogràfiques

Autors principals:	Akira Maeyama, Masakazu Kondo, Hiroshi Harada, Eisuke Shono, Ryuji Nagamine, Tomomi Tsuru, Yasushi Inoue, Munetoshi Nakashima, Yutaro Yamasaki, Hiroaki Niiro, Yasuharu Nakashima, Takuaki Yamamoto
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-12-01
Col·lecció:	BMC Rheumatology
Matèries:	Baricitinib JAK inhibitor Japan Propensity score matching Rheumatoid arthritis
Accés en línia:	https://doi.org/10.1186/s41927-024-00446-y
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!